PIII today
$2.59-$0.02 (-0.77%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minLeaning Bullish
5 minStrong Bearish
Daily trend turns up above $13.82
Key levels
Resistance$3.25
Resistance$2.73
Support$1.92
Latest news & SEC filings
AnalystTD Cowen keeps Hold rating on P3 Health Partners, cuts target to $4
SEC FilingP3 Health Partners Inc. filed a report on a major company event (Form 8-K)
GuidanceP3 Health Partners lifts FY2026 sales outlook to $1.525B-$1.600B
All PIII news →About P3 Health Partners
P3 Health Partners runs a care delivery business built around primary care doctors and manages health outcomes for seniors enrolled in Medicare Advantage plans. It receives fixed monthly payments from insurers for each member and partners with independent local doctors rather than buying their practices, adding its own employed physicians and clinics in some markets. The company operates in the United States.
Based on the company's 10-K filed Mar 26, 2026.
Nasdaq · Healthcare
P3 Health Partners Inc. (PIII)
What Is the Price Target for PIII?
SEPT Low Target
$14.00
SEPT Mid Target
$14.00
SEPT High Target
$14.00
Analyst Consensus
$14.00
Is PIII a Buy or Sell Right Now?
Thesis
- •Revenue growing -2.8% YoY with STABLE trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for PIII.
Start Free Trial →Is PIII Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$14.00
24
Moat Score
NONE
2/9
Piotroski Score
-1.3
Altman Z-Score
What Is Smart Money Doing with PIII?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →PIII Growth Story
Revenue YoY
-2.8%
3yr Revenue CAGR
11.6%
EPS Growth YoY
16.28%
FCF Growth YoY
N/A%
Revenue Trend
STABLE
Dark Pool Trades for PIII
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for PIII, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:40:30 | $2.59 | 1,000 | $$3K | SELL |
| 15:00:02 | $2.78 | 1,000 | $$3K | SELL |
| 15:00:02 | $2.78 | 1,000 | $$3K | SELL |
| 14:59:59 | $2.78 | 1,000 | $$3K | SELL |
| 19:52:43 | $2.80 | 2,098 | $$6K | SELL |
5 dark pool trades shown · $$17K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for P3 Health Partners Inc. (PIII) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →PIII — frequently asked questions
What is PIII stock price today?
P3 Health Partners Inc. (PIII) is at $2.59, down 0.77% (-$0.02) at the Nov 12, 2026 close.
Why is PIII stock moving today?
Latest PIII news — Nov 11, 2026: TD Cowen keeps Hold rating on P3 Health Partners, cuts target to $4 · Nov 9, 2026: P3 Health Partners Inc. filed a report on a major company event (Form 8-K)
What is the PIII price target?
The average analyst price target for PIII is $14.00, ranging from $14 to $14, based on 2 analysts. Latest: TD Cowen maintains on May 22, 2026.
What do analysts rate PIII?
Analyst ratings for PIII: 0 Buy, 4 Hold, 0 Sell — consensus Hold.
Did PIII beat earnings?
PIII last reported on Aug 10, 2026: EPS -$0.63 vs -$1.89 expected — a beat of 66.7%.
Does PIII pay a dividend?
PIII does not currently pay a dividend.
How much debt does PIII have?
P3 Health Partners Inc. reported $120M of debt and $21M of cash (Jun 30, 2026).
What are PIII support and resistance levels?
Support: $1.92. Resistance: $2.73, $3.25, $4.15.
What are insiders doing with PIII?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on PIII?
Nov 11, 2026: TD Cowen keeps Hold rating on P3 Health Partners, cuts target to $4 · Nov 9, 2026: P3 Health Partners Inc. filed a report on a major company event (Form 8-K) · Nov 9, 2026: P3 Health Partners lifts FY2026 sales outlook to $1.525B-$1.600B